{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:24Z","timestamp":1761896304626},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11255-016-1305-0","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T06:22:15Z","timestamp":1463552535000},"page":"1349-1355","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Switching from subcutaneous insulin injection to oral vildagliptin administration in hemodialysis patients with type 2 diabetes: a pilot study"],"prefix":"10.1007","volume":"48","author":[{"given":"Naoshi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Babazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Hanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Uchigata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"1305_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/1744-9987.12281","volume":"18","author":"S Nakai","year":"2014","unstructured":"Nakai S, Hanafusa N, Masakane I et al (2014) An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial 18:535\u2013602","journal-title":"Ther Apher Dial"},{"key":"1305_CR2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2337\/diacare.24.5.909","volume":"24","author":"T Morioka","year":"2001","unstructured":"Morioka T, Emoto M, Tabata T et al (2001) Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24:909\u2013913","journal-title":"Diabetes Care"},{"key":"1305_CR3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/db11-1015","volume":"61","author":"J Ricks","year":"2012","unstructured":"Ricks J, Molnar MZ, Kovesdy CP et al (2012) Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes. Diabetes 61:708\u2013715","journal-title":"Diabetes"},{"key":"1305_CR4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5414\/CN106940","volume":"78","author":"M Inaba","year":"2012","unstructured":"Inaba M, Maekawa K, Okuno S et al (2012) Impact of atherosclerosis on the relationship of glycemic control and mortality in diabetic patients on hemodialysis. Clin Nephrol 78:273\u2013280","journal-title":"Clin Nephrol"},{"key":"1305_CR5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00125-012-2473-9","volume":"55","author":"H Ishii","year":"2012","unstructured":"Ishii H, Kumada Y, Takahashi H et al (2012) Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis. Diabetologia 55:1304\u20131309","journal-title":"Diabetologia"},{"key":"1305_CR6","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00259-009-1110-4","volume":"36","author":"M Momose","year":"2009","unstructured":"Momose M, Babazono T, Kondo C et al (2009) Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging 36:1315\u20131321","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1305_CR7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1463-1326.2010.01222.x","volume":"12","author":"Y Iwamoto","year":"2010","unstructured":"Iwamoto Y, Kashiwagi A, Yamada N et al (2010) Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study. Diabetes Obes Metab 12:700\u2013708","journal-title":"Diabetes Obes Metab"},{"key":"1305_CR8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ11-0025","volume":"58","author":"M Ito","year":"2011","unstructured":"Ito M, Abe M, Okada K et al (2011) The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. Endocr J 58:979\u2013987","journal-title":"Endocr J"},{"key":"1305_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.2040-1124.2011.00169.x","volume":"3","author":"S Kume","year":"2012","unstructured":"Kume S, Uzu T, Takagi C et al (2012) Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis. J Diabetes Investig 3:298\u2013301","journal-title":"J Diabetes Investig"},{"key":"1305_CR10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/j.ajkd.2012.11.043","volume":"61","author":"JC Arjona Ferreira","year":"2013","unstructured":"Arjona Ferreira JC, Corry D et al (2013) Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis 61:579\u2013587","journal-title":"Am J Kidney Dis"},{"key":"1305_CR11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s13300-013-0029-8","volume":"4","author":"H Ito","year":"2013","unstructured":"Ito H, Mifune M, Matsuyama E et al (2013) Vildagliptin is effective for glycemic control in diabetic patients undergoing either hemodialysis or peritoneal dialysis. Diabetes Ther 4:321\u2013329","journal-title":"Diabetes Ther"},{"key":"1305_CR12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000351678","volume":"123","author":"Y Nakamura","year":"2013","unstructured":"Nakamura Y, Inagaki M, Shimizu T et al (2013) Long-term effects of alogliptin benzoate in hemodialysis patients with diabetes: a 2-year study. Nephron Clin Pract 123:46\u201351","journal-title":"Nephron Clin Pract"},{"key":"1305_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/14656566.2013.761690","volume":"14","author":"Y Fujii","year":"2013","unstructured":"Fujii Y, Abe M, Higuchi T et al (2013) The dipeptidyl-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis. Expert Opin Pharmacother 14:259\u2013267","journal-title":"Expert Opin Pharmacother"},{"key":"1305_CR14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/hdi.12127","volume":"18","author":"Y Nakamura","year":"2014","unstructured":"Nakamura Y, Tsuji M, Hasegawa H et al (2014) Anti-inflammatory effects of linagliptin in hemodialysis patients with diabetes. Hemodial Int 18:433\u2013442","journal-title":"Hemodial Int"},{"key":"1305_CR15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11255-013-0552-6","volume":"46","author":"H Otsuki","year":"2014","unstructured":"Otsuki H, Kosaka T, Nakamura K et al (2014) Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes. Int Urol Nephrol 46:427\u2013432","journal-title":"Int Urol Nephrol"},{"key":"1305_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561\u2013577","journal-title":"Clin Chem"},{"key":"1305_CR17","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New York","edition":"2"},{"key":"1305_CR18","volume-title":"The analysis of binary data","author":"DR Cox","year":"1989","unstructured":"Cox DR, Snell EJ (1989) The analysis of binary data, 2nd edn. Chapman & Hall, London","edition":"2"},{"key":"1305_CR19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","volume":"78","author":"NJD Nagelkerke","year":"1991","unstructured":"Nagelkerke NJD (1991) A note on a general definition of the coefficient of determination. Biometrika 78:691\u2013722","journal-title":"Biometrika"},{"key":"1305_CR20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jdi.12016","volume":"4","author":"J Kozawa","year":"2013","unstructured":"Kozawa J, Kitamura T, Nishizawa H et al (2013) Dipeptidyl peptidase-4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin-secreting capacity, a higher body mass index and insulin resistance. J Diabetes Investig 4:190\u2013194","journal-title":"J Diabetes Investig"},{"key":"1305_CR21","first-page":"231","volume":"45","author":"SI Harashima","year":"2013","unstructured":"Harashima SI, Tanaka D, Yamane S et al (2013) Efficacy and safety of switching from basal insulin to sitagliptin in Japanese type 2 diabetes patients. Horm Metab Res 45:231\u2013238","journal-title":"Horm Metab Res"},{"key":"1305_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1681\/ASN.2006070772","volume":"18","author":"M Inaba","year":"2007","unstructured":"Inaba M, Okuno S, Kumeda Y et al (2007) Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 18:896\u2013903","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"1305_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1744-9987.12299","volume":"19","author":"T Nakao","year":"2015","unstructured":"Nakao T, Inaba M, Abe M et al (2015) Best practice for diabetic patients on hemodialysis 2012. Ther Apher Dial 19(Suppl 1):40\u201366","journal-title":"Ther Apher Dial"},{"key":"1305_CR24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.ajkd.2008.04.011","volume":"52","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Sharma K, Kalantar-Zadeh K (2008) Glycemic control in diabetic CKD patients: Where do we stand? Am J Kidney Dis 52:766\u2013777","journal-title":"Am J Kidney Dis"},{"key":"1305_CR25","first-page":"239","volume":"38","author":"PY Benhamou","year":"1992","unstructured":"Benhamou PY, Marwah T, Balducci F et al (1992) Classification of diabetes in patients with end-stage renal disease. Validation of clinical criteria according to fasting plasma C-peptide. Clin Nephrol 38:239\u2013244","journal-title":"Clin Nephrol"},{"key":"1305_CR26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.106.672402","volume":"115","author":"NR Cook","year":"2007","unstructured":"Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928\u2013935","journal-title":"Circulation"},{"key":"1305_CR27","volume-title":"Logistic regression using SAS: theory and application","author":"PD Allison","year":"2012","unstructured":"Allison PD (2012) Logistic regression using SAS: theory and application, 2nd edn. SAS Institute, Cary","edition":"2"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1305-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-016-1305-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-016-1305-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T23:22:37Z","timestamp":1600557757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-016-1305-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1007\/s11255-016-1305-0","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}